Pneumologia5 articoli

Impatto 2

Biomarkers of radioresistance in lung cancer: Current insights and future directions (Review).

Pubblicato: 2026-07-01

Molecular medicine reports

MediLens Indicizzato: 2026-05-23

This review discusses the challenges of radioresistance in lung cancer management, highlighting its role in therapeutic failure and increased mortality. It emphasizes the need for a deeper understanding of the molecular mechanisms driving radioresistance, which could lead to the identification of...

Leggi su PubMed

Impatto 2

Ginsenoside Rg3 potentiates cisplatin antitumor activity while mitigating nephrotoxicity through SIRT1‑mediated suppression of the NLRP3 inflammasome.

Pubblicato: 2026-07-01

International journal of molecular medicine

MediLens Indicizzato: 2026-05-23

The study explores the therapeutic effects of Ginsenoside Rg3 in combination with cisplatin on lung carcinoma cells, addressing the limitations of cisplatin due to nephrotoxicity and drug resistance.

Leggi su PubMed

Impatto 3

Lung Cancer Screening and Prevention: Beyond Conventional Strategies in a Rapidly Changing Global Milieu.

Pubblicato: 2026-06-01

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

MediLens Indicizzato: 2026-05-23

Lung cancer continues to be the leading cause of cancer-related deaths globally, with a notable increase in cases among never-smokers, particularly in East Asian women. This review emphasizes the need for a shift in lung cancer screening strategies, advocating for comprehensive computed tomograph...

Leggi su PubMed

Impatto 2

Light-controlled disruption of cancer cell dormancy via photoswitchable stress hormone receptor degraders.

Pubblicato: 2026-05-26

Proceedings of the National Academy of Sciences of the United States of America

MediLens Indicizzato: 2026-05-23

This study explores the role of the glucocorticoid receptor in cancer cell dormancy and proposes a novel approach using photoPROTACs for targeted modulation of GR degradation. The findings suggest potential advancements in overcoming therapy resistance in non-lymphoid solid tumors, particularly l...

Leggi su PubMed

Impatto 3

Evolving trends and outcomes in living and deceased donor liver transplantation: institutional experience from Changwon Hanmaeum Hospital (2023-2025).

Pubblicato: 2026-05-22

Clinical transplantation and research

MediLens Indicizzato: 2026-05-23

This study evaluates liver transplantation outcomes at Changwon Hanmaeum Hospital over a 2.5-year period, highlighting the importance of institutional experience in optimizing results. A total of 56 liver transplants were performed, with 82.1% of patients surviving to discharge. Notably, outcomes...

Leggi su PubMed

Tendenze della Ricerca Medica

Pneumologia5 articoli

Biomarkers of radioresistance in lung cancer: Current insights and future directions (Review).

Ginsenoside Rg3 potentiates cisplatin antitumor activity while mitigating nephrotoxicity through SIRT1‑mediated suppression of the NLRP3 inflammasome.

Lung Cancer Screening and Prevention: Beyond Conventional Strategies in a Rapidly Changing Global Milieu.

Light-controlled disruption of cancer cell dormancy via photoswitchable stress hormone receptor degraders.

Evolving trends and outcomes in living and deceased donor liver transplantation: institutional experience from Changwon Hanmaeum Hospital (2023-2025).

Ricevi riassunti giornalieri personalizzati